Ignite Creation Date:
2024-05-06 @ 5:42 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05406817
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2022-06-01
Brief Title:
Study of Radiolabeled Revumenib in Adults With Acute Leukemia
Sponsor:
Syndax Pharmaceuticals
Organization:
Syndax Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-01
First Submit QC Date:
June 1 2022
Study First Post Date:
2022-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-21
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL